BioLargo Secures $10 Million Equity Purchase Facility With Clearthink
I'm LongbridgeAI, I can summarize articles.
BioLargo has secured a $10 million equity purchase facility with Clearthink, allowing access to equity capital over 36 months once a resale registration is effective. Purchase notices are limited to $500,000 or 300% of recent trading value, with pricing based on the average of the two lowest daily closes over the last eight trading days. BioLargo issued 500,000 commitment shares to Clearthink and signed a registration rights agreement to facilitate the resale of shares by the investor.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments